| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced the successful completion of a joint field trial of its DropAir system for the precision delivery of blood units.
The trial was conducted in collaboration with MAFAT (the Israeli Ministry of Defense Directorate of Defense R&D), the Israeli Ministry of Health, and the Israel Defense Forces (IDF), including the Medical Corps and Technology & Logistics Directorate (ATAL).
During the trial, blood Transfusions were dropped from an altitude of 200 meters AGL using ParaZero's DropAir system. Following recovery, the Transfusions were inspected by doctors at the Rambam Medical center and confirmed to be undamaged and fully suitable for transfusion to humans.
Posted In: PRZO
